Metabolic syndrome as an interdisciplinary problem (literature review)

Main Article Content

R.P. Liashuk
P.M. Liashuk


The article analyzes the literature data concerning the diagnostic criteria and combination of metabolic syndrome and its components (arterial hypertension, obesity, insulin resistance, dyslipidemia) with a number of diseases, in which the pathogenesis plays a significant role in metabolic disorders. Therefore, metabolic syndrome should be considered as an interdisciplinary problem, especially because co- and polymorbidity with its participation develop with age.

Article Details

How to Cite
Liashuk, R., and P. Liashuk. “Metabolic Syndrome As an Interdisciplinary Problem (literature Review)”. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine), vol. 13, no. 7, Nov. 2017, pp. 499-02, doi:10.22141/2224-0721.13.7.2017.115748.
Literature Review


Reaven G. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988;37:1595-1607. PMID: 3056758.

Кahn R, Buse J, Ferranini E, Stern M. The metabolic syndrome: time for a critical appraisal. Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia. 2005 Sep;48(9):1684-99. doi: 10.1007/s00125-005-1876-2.

Shlyakhto EV, Baranova EI, Beliaeva OV, Bol'shakova OO. Metabolic syndrome: the past, present and future. Efferentnaia terapiia. 2007;13(1):74-77. (in Russian).

Shlyakhto EV, Konrady АО. Epidemiology of metabolic syndrome in different regions. Impact of used definitions and prognostic value. Arterial’naya Gipertenziya. 2007;13(2):95-112. (in Russian).

Pankiv VI. Insulin resistance as key pathophysiological mechanism of metabolic syndrome. Praktychna angiologija.2012;5-6(54-55):24-28. (in Ukrainian).

Sperling LS, Mechanick JI, Neeland IJ, at al. The CardioMetabolic Health Alliance: Working Toward a New Care Model for the Metabolic Syndrome. J Am Coll Cardiol. 2015 Sep 1;66(9):1050-67. doi: 10.1016/j.jacc.2015.06.1328.

Mishchenko N. Type 2 diabetes mellitus and metabolic syndrome: what the practitioner needs to know about the companions of diabetes? Zdorov’ja Ukrai'ny. 2014;10(335):29. (in Russian).

Oganov RG. Current idea about metabolic syndrome: concept, epidemiology, risk of development of cardiovascular complications and diabetes mellitus. Mezhdunarodnyi Endokrinologicheskii Zhurnal. 2008;6(18):106-109. (in Russian).

Mamedov MN. Meaningfulness of metabolic syndrome in clinical practice: diagnostic bases and ways of medicamental correction. Mezhdunarodnyi Endokrinologicheskii Zhurnal. 2007;2(8):100-103. (in Russian).

Skrypnyk NV, Vaсeba TS. Metabolic syndrome and hypothyroidism: pathogenetic interrelations, diagnostic and treatment. Zdorov’ja Ukrai'ny. Diabetologija, Tyreoi'dologija, Metabolichni rozlady 2017 March;1(37):60-63. (in Ukrainian).

Kopchak OO. Сontribution of metabolic syndrome in the development of vascular cognitive impairment. Ukrainian Medical Journal. 2014;2:178-182. (in Ukrainian).

Liashuk RP, Liashuk PM, Hluhovska SV. Comorbidity of metabolic syndrome and sleep apnea. Buk Med Herald. 2015;19(3):273-275. (in Ukrainian).

Liashuk RP, Liashuk PM, Marchuk YuF, Skhodnytskyi IV, Melnik LM. Comorbidity of diabetes mellitus type 2 and obesity (literature review). Klinichna ta eksperymental'na patologija. 2016;15(1):198-200. (in Ukrainian).

Kolomoiets MYu, Vashenyak OO. Comorbidity and multimorbidity in therapeutical practice. Ukrainian Medical Journal. 2012;5(91):140-143. (in Ukrainian).

Hamilton EY, Gianatti E, Strauss BY, et al. Increase in visceral and subcutaneous abdominal fat in men with prostate cancer treated with androgen deprivation therapy. Clin Endocrinol (Oxf). 2011 Mar;74(3):377-83. doi: 10.1111/j.1365-2265.2010.03942.x.

Ljashuk PМ, Morozjuk JaV. Insulin resistance in patients with polycystic ovary syndrome. Mezhdunarodnyi Endokrinologicheskii Zhurnal. 2013;6(54):112-113. (in Ukrainian).

Tronko MD. The current state and prospects of development of fundamental and clinical endocrinology in the period from 2015 to 2020 years. Endokrynologia. 2015;20(1):373-380. (in Ukrainian).

Kozakov OV, Il'i'na IM. Endocrine pathology in the age aspect. In: Proceeding of the 12th scientific-practical conference with international participation. 2014 Nov 27-28; Kharkov, Ukraine. Problemi endokrynnoi patologii. 2014;4:95-101. (in Ukrainian).

Fediv AI, Fediv AI, Melnyk OB. Analysis of Proteolytic and Fibrinolytic Activity of the Blood Plasma in Patients with Bronchial Asthma Combined with Obesity. Mezhdunarodnyi Endokrinologicheskii Zhurnal. 2016;6(78):24-27. (in Ukrainian).

Tkachenko EI, Uspenski IuP, Belousova LN, Petrenko VV. Non-alcoholic fatty liver disease and metabolic syndrome: unity of nosotropic mechanisms and treatment. Eksperimental'naia i klinicheskaia gastroenterologiia. 2008;2:92-96. (in Russian).

Zhuo O, Yang W, Chen J, Wang Y. Metabolic syndrome meets osteoarthritis. Nat Rev Rheumatol. 2012 Dec;8(12):729-37. doi: 10.1038/nrrheum.2012.135.

Magliano M.Obesity and Arthritis. Menopause Int. 2008 Dec;14(4):149-54. doi: 10.1258/mi.2008.008018.

Richette P, Funk-Brentano T. What is New in Osteoarthritis Front? Eur Musculoskel Rev. 2010;5(2):8-10.

Katz JD, Agrawal S, Velasques M. Getting to the heard of matter: osteoarthritis takes its place as part of the metabolic syndrome. Curr Opin Rheumatol. 2010 Sep;22(5):512-9. doi: 10.1097/BOR.0b013e32833bfb4b.

Pankiv VI, Gavryljuk VM, Neporadna LD, et al. Intercommunication between structural-functional violations of thyroid gland and components of metabolic syndrome. Mezhdunarodnyi Endokrinologicheskii Zhurnal. 2011;6(38):39-43. (in Ukrainian).

Biondi B, Cooper DS. The clinical significance of subclinical thyroid dysfunction. Endocr Rev. 2008 Feb;29(1):76-131. doi: 10.1210/er.2006-0043.

Abramova NO, Pashkovska NV. Peculiarities of Indices of Thyroid Homeostasis in Patients with Metabolic Syndrome Depending on Body Mass Index. Mezhdunarodnyi Endokrinologicheskii Zhurnal. 2015;8(72):27-30. (in Russian).

Zhuravlyova LV, Moyiseyenko TA. Thyroid status in patients with obesity of different degree. Endokrinologia. 2016;21(1):26-32. (in Russian).

Yuzvenko TYu. Relation between Hormonal Disorders and Components of Metabolic Syndrome in Patients with Primary Hypothyroidism. Mezhdunarodnyi Endokrinologicheskii Zhurnal. 2016;6(78):66-70. (in Ukrainian).

Amati F, Dube YY, Stefanovic-Racic M, Toledo FG, Goodpaster BH. Improvements in insulin sensitivity are blunted by subclinical hypothyroidism. Med Sci Sports Exerc. 2009 Feb;41(2):265-9. doi: 10.1249/MSS.0b013e318187c010.

Mamedgasanov PM, Mekhtiev TV. Age-related androgen deficiency and erectile dysfunction in men of reproductive age presenting with type 2 diabetes mellitus. Problemi endokrinologii. 2013;59(1):3-7. (in Russian).

Huhtaniemi I. Late-onset hypogonadism: current conceps and controversiens of pathogenesis diagnosis and treatment. Asian J Androl. 2014 Mar-Apr;16(2):192-202. doi: 10.4103/1008-682X.122336.

Cherenko S, Tovkay O, Shchekaturova L, Tretiak O. Subclinical Cushing’s syndrome and its importance for endocrinology and adrenal surgery. Clinical endocrinology and endocrine surgery. 2014;2(47):25-31. (in Ukrainian).

Tovazhnianskaya LE, Bezuglova IO, Nasruzov MB, Balkovaya NS. Moderate cognitive disorders in type 2 diabetes mellitus. Mezhdunarodnyi meditsinskii zhurnal. 2012;1:6-9. (in Russian).

Nasonova TI. Pathogenetic Aspects of Preventive Correction of Cognitive Impairment in Metabolic Syndrome. Mezhdunarodnyi Endokrinologicheskii Zhurnal. 2016;1(73):61-69. (in Ukrainian).

Dzherieva IS, Volkova NI, Rapoport SI. Association between depression and metabolic syndrome. Klinicheskaia meditsina. 2015;63(1):62-65. (in Russian).

Voloshyn OI, Dogolich OI. Age-old features of clinic and motion of gout on background of metabolic syndrome. Mezhdunarodnyi Endokrinologicheskii Zhurnal. 2013;6(54):156-159. (in Ukrainian).